Dochez, V.; Randet, M.; Renaudeau, C.; Dimet, J.; Le Thuaut, A.; Winer, N.; Thubert, T.; Vaucel, E.; Caillon, H.; Ducarme, G.
Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. J. Clin. Med. 2019, 8, 1784.
https://doi.org/10.3390/jcm8111784
AMA Style
Dochez V, Randet M, Renaudeau C, Dimet J, Le Thuaut A, Winer N, Thubert T, Vaucel E, Caillon H, Ducarme G.
Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. Journal of Clinical Medicine. 2019; 8(11):1784.
https://doi.org/10.3390/jcm8111784
Chicago/Turabian Style
Dochez, Vincent, Mélanie Randet, Céline Renaudeau, Jérôme Dimet, Aurélie Le Thuaut, Norbert Winer, Thibault Thubert, Edouard Vaucel, Hélène Caillon, and Guillaume Ducarme.
2019. "Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial" Journal of Clinical Medicine 8, no. 11: 1784.
https://doi.org/10.3390/jcm8111784
APA Style
Dochez, V., Randet, M., Renaudeau, C., Dimet, J., Le Thuaut, A., Winer, N., Thubert, T., Vaucel, E., Caillon, H., & Ducarme, G.
(2019). Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial. Journal of Clinical Medicine, 8(11), 1784.
https://doi.org/10.3390/jcm8111784
